Emerging Research

Emerging Research

Emerging Role of MDM2 in Myelofibrosis Care

What is MDM2 and what does it mean for myelofibrosis patients? Watch as Dr. Srdan Verstovsek explains the mechanism of action of the MDM2 inhibitor and which patient population it may benefit.

Srdan Verstovsek, MD, PhD, Andrew Schorr

Emerging Research

MPN Researcher Shares Optimism for Future Treatment

Expert Dr. Jason Gotlib gives an overview of the progress to improve treatment durability and efficacy for MPN patients. Watch now to learn his expert knowledge.

Andrew Schorr, Jason Gotlib, MD, MS

Latest News

Emerging Research

MDM2 Study: How Can Polycythemia Vera Patients Get Involved?

Andrew Schorr, Jason Gotlib, MD, MS

Emerging Research

Can Hypomethylating Agents Be Used for MPNs?

Guillermo Garcia-Manero, MD, Andrew Schorr

Emerging Research

Experts Explain MDM2 Inhibition and Clinical Trial for MPN Patients

Andrew Schorr, Jason Gotlib, MD, MS, Srdan Verstovsek, MD, PhD

Emerging Research

A Sneak Peek of Our Coverage on MDM2 Inhibition

Emerging Research

Expert Perspective: Encouraging Research Developments in the Treatment of MPNs

Andrew Schorr, Naval G. Daver, MD

Emerging Research

Hope and Progress in MPN Treatment: Updates From an Expert

Brandon McMahon, MD, Andrew Schorr

Emerging Research

The Latest MPN News: What the Experts Learned at ASH 2017

Angela Fleischman, MD, PhD, John Crispino, PhD, MBA, Andrew Schorr

Emerging Research

ASH 2017 Coverage: An Interferon Update From an MPN Expert

Srdan Verstovsek, MD, PhD, Esther Schorr

Emerging Research

Research Updates for Essential Thrombocythemia and Polycythemia Vera

Andrew Schorr

Emerging Research

Expert Perspective: Advancing MPN Treatment Through Education and Clinical Trials

Find a clinical trial

Learn More